A Novel Method for Creating a Synthetic L-DOPA Proteome and In Vitro Evidence of Incorporation
- PMID: 34073856
- PMCID: PMC8162537
- DOI: 10.3390/proteomes9020024
A Novel Method for Creating a Synthetic L-DOPA Proteome and In Vitro Evidence of Incorporation
Abstract
Proteinopathies are protein misfolding diseases that have an underlying factor that affects the conformation of proteoforms. A factor hypothesised to play a role in these diseases is the incorporation of non-protein amino acids into proteins, with a key example being the therapeutic drug levodopa. The presence of levodopa as a protein constituent has been explored in several studies, but it has not been examined in a global proteomic manner. This paper provides a proof-of-concept method for enzymatically creating levodopa-containing proteins using the enzyme tyrosinase and provides spectral evidence of in vitro incorporation in addition to the induction of the unfolded protein response due to levodopa.
Keywords: L-DOPA; Levodopa; PTM; misincorporation; post-translational modifications.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Alexander T., Sortwell C.E., Sladek C.D., Roth R.H., Steece-Collier K. Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplant. 1997;6:309–315. doi: 10.1177/096368979700600313. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
